References
- Thorstensen K, Kvitland MA, Irgens WØ, Hveem K, Asberg A. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation. Scand J Clin Lab Invest 2010;70:92–7.
- Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjøsne U, Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108–15.
- Asberg A, Hveem K, Kruger O, Bjerve KS. Persons with screening-detected haemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002;37:719–24.
- Adams PC. The natural history of untreated HFE-related hemochromatosis. Acta Haematol 2009;122:134–9.
- Allen KJ, Bertalli NA, Osborne NJ, Constantine CC, Delatycki MB, Nisselle AE, HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology 2010;52:925–33.
- Barton JC, Barton JC, Acton RT, So J, Chan S, Adams PC. Increased risk of death from iron overload among 422 treated probands with hfe hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis. Clin Gastroenterol Hepatol 2012;10:412–16.
- Osborne NJ, Gurrin LC, Allen KJ, Constantine CC, Delatycki MB, McLaren CE, HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 2010;51:1311–18.
- Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Risk of cancer by transferrin saturation levels and haemochromatosis genotype: population-based study and meta-analysis. J Intern Med 2012;271:51–63.
- Steegmann-Olmedillas JL. The role of iron in tumour cell proliferation. Clin Transl Oncol 2011;13:71–6.
- Fargion S, Valenti L, Fracanzani AL. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload. Hepatology 2010;51:1119–21.
- Kovac S, Anderson GJ, Baldwin GS. Gastrins, iron homeostasis and colorectal cancer. Biochim Biophys Acta 2011;1813:889–95.
- Costanza ME, Chen WY. Epidemiology and risk factors for breast cancer. In Basow DS, editor. UpToDate. Waltham: UpToDate; 2012.
- Royston P, Sauerbrei W. Multivariable modeling with cubic regression splines: A principled approach. Stata Journal 2007;7:45–70.
- Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA. Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res 2010;12:R106.
- Ekblom K, Marklund SL, Palmqvist R, Van Guelpen B, Hallmans G, Weinehall L, Iron Biomarkers in Plasma, HFE Genotypes, and the Risk for Colorectal Cancer in a Prospective Setting. Diseases of the Colon & Rectum 2012;55:337–44.
- Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology 2007;46:1071–80.
- Gannon PO, Medelci S, Le Page C, Beaulieu M, Provencher DM, Mes-Masson AM, Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis. Int J Cancer 2011;128:2326–34.